ATE238065T1 - Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus - Google Patents
Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virusInfo
- Publication number
- ATE238065T1 ATE238065T1 AT91917502T AT91917502T ATE238065T1 AT E238065 T1 ATE238065 T1 AT E238065T1 AT 91917502 T AT91917502 T AT 91917502T AT 91917502 T AT91917502 T AT 91917502T AT E238065 T1 ATE238065 T1 AT E238065T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- immunodeficiency virus
- human immunodeficiency
- against human
- vaccination
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58942290A | 1990-09-27 | 1990-09-27 | |
| PCT/SE1991/000641 WO1992005800A1 (en) | 1990-09-27 | 1991-09-25 | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE238065T1 true ATE238065T1 (de) | 2003-05-15 |
Family
ID=24357953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91917502T ATE238065T1 (de) | 1990-09-27 | 1991-09-25 | Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5589175A (de) |
| EP (1) | EP0550599B1 (de) |
| JP (1) | JPH06501260A (de) |
| AT (1) | ATE238065T1 (de) |
| AU (1) | AU650911B2 (de) |
| CA (1) | CA2091263C (de) |
| DE (1) | DE69133242T2 (de) |
| ES (1) | ES2194836T3 (de) |
| FI (1) | FI931393A7 (de) |
| HU (1) | HU9300877D0 (de) |
| MC (1) | MC2308A1 (de) |
| OA (1) | OA09802A (de) |
| WO (1) | WO1992005800A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939074A (en) * | 1986-12-30 | 1999-08-17 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens |
| US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
| JPH06510025A (ja) * | 1991-06-03 | 1994-11-10 | シンテロ ヴァクシン デベロップメント アクチ ボラゲット | Hiv−1に対するt細胞活性化の誘導に用いられるペプチド |
| EP0601108B1 (de) * | 1991-08-29 | 1999-10-06 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Peptid-antigene bestehend aus multi-determinanten, die die t-helfer lymphozyten-antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren |
| IT1254360B (it) * | 1992-05-11 | 1995-09-14 | San Romanello Centro Fond | Epitopi immunologicamente omologhi di hla e proteine del virus hiv. |
| DE4228787A1 (de) * | 1992-08-29 | 1994-03-03 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate |
| ATE247485T1 (de) * | 1993-04-16 | 2003-09-15 | Tripep Ab | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus |
| FR2707170A1 (fr) * | 1993-06-04 | 1995-01-13 | Pasteur Institut | Expression des récepteurs CD4 et CD26 dans des cellules recombinantes, inhibiteurs du récepteur CD26. |
| FR2707169B1 (fr) * | 1993-06-04 | 1995-09-01 | Pasteur Institut | Antigène cellulaire CD26 impliqué dans l'infection par un rétrovirus hiv. nouveaux inhibiteurs de l'infection par HIV. * (Dipeptidyl-peptidase IV). |
| DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
| AU2991197A (en) * | 1996-04-15 | 1997-11-07 | University Of North Carolina At Chapel Hill, The | Antigenic sequences of a sperm protein and immunocontraceptive methods |
| WO1999024465A1 (en) * | 1997-11-10 | 1999-05-20 | Dana-Farber Cancer Institute | Stabilized primate lentivirus envelope glycoproteins |
| WO2008017517A1 (en) | 2006-08-11 | 2008-02-14 | Life Sciences Research Partners Vzw | Immunogenic peptides and their use in immune disorders |
| US20120009678A1 (en) | 2008-02-14 | 2012-01-12 | Jean-Marie Saint-Remy | Immunotherapy targeting intracellular pathogens |
| WO2009101205A2 (en) | 2008-02-14 | 2009-08-20 | Life Sciences Research Partners Vzw | Immunogenic control of tumours and tumour cells |
| US10023847B2 (en) * | 2010-11-25 | 2018-07-17 | Imnate Sarl | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination |
| GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
| GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| GB201418433D0 (en) | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
| US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
| EP3352782B1 (de) | 2015-09-25 | 2021-03-31 | ImCyse SA | Verbesserte verfahren und verbindungen zur beseitigung von immunreaktionen auf therapeutische mittel |
| WO2017182528A1 (en) | 2016-04-19 | 2017-10-26 | Imcyse Sa | Novel immunogenic cd1d binding peptides |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0387915B1 (de) * | 1984-10-18 | 1993-03-10 | Institut Pasteur | F Antigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen |
| AU617088B2 (en) * | 1986-06-12 | 1991-11-21 | Biogen, Inc. | Peptides involved in the pathogenesis of hiv infection |
| US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
| US5019387A (en) * | 1987-09-08 | 1991-05-28 | Duke University | Production of antibodies to HIV |
| WO1989005820A1 (en) * | 1987-12-21 | 1989-06-29 | Arch Development Corporation | Hiv-related antigens and antibodies |
| EP0330359A3 (de) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion |
| AU3557889A (en) * | 1988-04-20 | 1989-11-24 | Trustees Of The University Of Pennsylvania, The | Protective peptides derived from human immunodeficiency virus-1 gp160 |
| US4943628A (en) * | 1988-06-13 | 1990-07-24 | Ortho Pharmaceutical Corporation | HIV peptide-inducted T cell stimulation |
| AU7676891A (en) * | 1990-04-03 | 1991-10-30 | Genentech Inc. | Hiv envelope polypeptides |
| AP237A (en) * | 1990-05-29 | 1993-04-29 | Cedars Sinai Medical Center | Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use. |
| JPH06510025A (ja) * | 1991-06-03 | 1994-11-10 | シンテロ ヴァクシン デベロップメント アクチ ボラゲット | Hiv−1に対するt細胞活性化の誘導に用いられるペプチド |
-
1991
- 1991-09-25 JP JP3516126A patent/JPH06501260A/ja active Pending
- 1991-09-25 AT AT91917502T patent/ATE238065T1/de not_active IP Right Cessation
- 1991-09-25 FI FI931393A patent/FI931393A7/fi not_active Application Discontinuation
- 1991-09-25 ES ES91917502T patent/ES2194836T3/es not_active Expired - Lifetime
- 1991-09-25 WO PCT/SE1991/000641 patent/WO1992005800A1/en not_active Ceased
- 1991-09-25 AU AU86435/91A patent/AU650911B2/en not_active Ceased
- 1991-09-25 EP EP91917502A patent/EP0550599B1/de not_active Expired - Lifetime
- 1991-09-25 HU HU93877A patent/HU9300877D0/hu unknown
- 1991-09-25 CA CA002091263A patent/CA2091263C/en not_active Expired - Fee Related
- 1991-09-25 DE DE69133242T patent/DE69133242T2/de not_active Expired - Fee Related
- 1991-09-27 MC MC912308D patent/MC2308A1/xx unknown
-
1993
- 1993-03-23 OA OA60353A patent/OA09802A/en unknown
-
1995
- 1995-03-27 US US08/410,384 patent/US5589175A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| OA09802A (en) | 1994-04-15 |
| WO1992005800A1 (en) | 1992-04-16 |
| EP0550599B1 (de) | 2003-04-23 |
| FI931393L (fi) | 1993-03-26 |
| AU650911B2 (en) | 1994-07-07 |
| DE69133242D1 (de) | 2003-05-28 |
| CA2091263C (en) | 2003-05-06 |
| EP0550599A1 (de) | 1993-07-14 |
| US5589175A (en) | 1996-12-31 |
| DE69133242T2 (de) | 2004-02-19 |
| MC2308A1 (fr) | 1993-09-27 |
| CA2091263A1 (en) | 1992-03-28 |
| FI931393A0 (fi) | 1993-03-26 |
| HU9300877D0 (en) | 1993-06-28 |
| ES2194836T3 (es) | 2003-12-01 |
| AU8643591A (en) | 1992-04-28 |
| FI931393A7 (fi) | 1993-03-26 |
| JPH06501260A (ja) | 1994-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69133242D1 (de) | Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus | |
| NO20022531L (no) | Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer | |
| TR199801722T2 (xx) | Peptit imm�nojenler. | |
| PE20040554A1 (es) | Vacunas que comprenden proteinas de fusion | |
| DE69824013D1 (de) | Impfstoff gegen hpv | |
| DE68918867D1 (de) | Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen. | |
| ATE125157T1 (de) | Methoden und zusammensetzungen zur impfung gegen hiv. | |
| DK1278534T3 (da) | Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1 | |
| ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
| ES2102347T3 (es) | Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv. | |
| ATE135743T1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
| ATE206620T1 (de) | Menschliche, monoklonale antikörper gegen das transmembrane glycoprotein (gp41) des hiv-1, und verwandte peptide | |
| ES2072928T3 (es) | Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular. | |
| RU94045907A (ru) | Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты | |
| DE69330352D1 (de) | Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut | |
| ATE285418T1 (de) | Humanisierter antikörper spezifisch für das oberflächenantigen pre-s1 von hbv und dessen präparation | |
| DE69007571D1 (de) | Peptidfragmente von HIV. | |
| ATE119203T1 (de) | Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. | |
| ATE435034T1 (de) | Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist. | |
| BR9105717A (pt) | Receptor poli-ig sintetico,complexos de receptor-anticorpo,sua producao e uso | |
| ATE109158T1 (de) | Rubella-e1 und c peptide. | |
| DE69840628D1 (de) | Nicht-anaphylaktische allergenarten und ihre verwendung | |
| DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
| DK0426314T3 (da) | HIV-relaterede peptider | |
| DE69010897D1 (de) | Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |